Middle East and Africa IVF Market
Middle East and Africa In-Vitro Fertilization (IVF) Market Size Booming at Significant CAGR of about 7% to Surpass USD 4.1 Billion by 2030
Published | 21 March 2024
Middle East and Africa In-Vitro Fertilization (IVF) Market is flourishing because of the increasing awareness about fertility treatments and the rapid adoption of advancements in IVF technology.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Middle East and Africa In-Vitro Fertilization (IVF) Market size at USD 2.46 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Middle East and Africa In-Vitro Fertilization (IVF) Market size to expand at a CAGR of 6.88% reaching a value of USD 4.11 billion by 2030. The rising prevalence of infertility and the rise of reproductive tourism in the Middle East and Africa are two of the key growth drivers for the In-Vitro Fertilization (IVF) market. Additionally, the Middle East and Africa In-Vitro Fertilization (IVF) Market is expected to provide significant growth opportunities due to growing awareness about the availability of fertility treatments and improvements in IVF technology.
Opportunity: Increasing number of fertility clinics in Middle East and Africa
The Middle East and Africa In-Vitro Fertilization (IVF) Market is segmented into fertility clinics, hospitals & surgical centers, cryobanks, and research institutes, based on end user. The fertility clinic segment accounts for the highest market share. The increasing number of fertility clinics in Middle East and African countries and the availability of experienced professionals with specializations in infertility treatments contribute to the segment’s growth. Hospitals & surgical centers are anticipated to grow at a substantial rate over the forecast period.
Middle East and Africa In-Vitro Fertilization (IVF) (IVF) Market
Segmental Coverage
Middle East and Africa In-Vitro Fertilization (IVF) Market – By Cycle
Based on cycle, the Middle East and Africa In-Vitro Fertilization (IVF) Market is segmented into fresh non-donor cycle, frozen non-donor IVF cycle, frozen donor IVF cycle, and fresh donor IVF cycle. The frozen non-donor IVF cycle holds the largest share in the Middle East and Africa In-Vitro Fertilization (IVF) Market. The procedure's less invasive nature and cost-effectiveness in comparison to fresh non-donors are the two major aspects that contribute to the segment's growth. The fresh donor segment is anticipated to grow considerably over the period in analysis.
Sample Request @ https://www.blueweaveconsulting.com/report/middle-east-and-africa-in-vitro-fertilization-market/report-sample
Middle East and Africa In-Vitro Fertilization (IVF) Market – By Country
The in-depth research report on the Middle East and Africa In-Vitro Fertilization (IVF) Market covers a number of country-specific markets, including Saudi Arabia, the UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, and the rest of MEA. UAE dominates the Middle East and Africa In-Vitro Fertilization (IVF) Market owing to a high rate of pregnancies in the country compared to not only in the MEA region but also in the rest of the world. Stringent government regulations and frameworks in the UAE ensure high-quality fertility treatment. Following the UAE, Saudi Arabia is also growing at a substantial rate owing to rising investment in healthcare infrastructure.
Competitive Landscape
Major players operating in the Middle East and Africa In-Vitro Fertilization (IVF) Market include CooperSurgical, Inc., Thermo Fisher Scientific, Inc., EMD Serono, Inc., ESCO Micro Pte Limited, IVFtech ApS, The Baker Company, Inc., Devex, International Technical Legacy, and bioMérieux. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Middle East and Africa In-Vitro Fertilization (IVF) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Middle East and Africa In-Vitro Fertilization (IVF) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Get Help
Related Report
Publish Date: March 2024
Rapid adoption of advancements in IVF technology and growing awareness about fertility treatments are expected to boost the growth of Middle East and Africa In-Vitro Fertilization (IVF) Market during the forecast period between 2024 and 2030.
Relevant Press Releases
- Global Patient Engagement Solutions Market to Reach USD 32 Billion by 2028
- Global Compression Therapy Market Growth Sturdy at 4.8% CAGR: Projected to Outstrip USD 4.7 Billion by the End of 2027
- Global Bone & Joint Health Supplements Market to Grow at a CAGR of 9.2%, during Forecast Period
- Blood Bag Market has reached USD 290 Million in 2019 and is further projected to reach USD 629.17 Million by 2026
- Pharmaceutical Excipients Market is Forecast to Grow at a CAGR of 5.80% in the Forecast Period